XYCOS PINK COLLAGEN

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: XYCOS PINK COLLAGEN
Generic name: ADENOSINE, NIACINAMIDE
Manufacturer: NOKSIBCHO cosmetic Co., Ltd.
Product type: HUMAN OTC DRUG
SPL set ID: a22c9f95-e3ab-bfd3-e053-2995a90a3c66
SPL ID: a22ca66a-44ec-efcc-e053-2995a90a027c
Version: 1
Effective date: 2020-03-31
Source export date: 2026-10-27
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/d7629e6f844435cfe6cb0cf8c5341c46775ea16c5af42c77a22a2ffe820a2cd2/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 19:53:56

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		XYCOS PINK COLLAGEN	openfda.brand_name
generic name		ADENOSINE, NIACINAMIDE	openfda.generic_name
manufacturer name		NOKSIBCHO cosmetic Co., Ltd.	openfda.manufacturer_name
ndc	package	73590-0045-1	openfda.package_ndc
ndc	product	73590-0045	openfda.product_ndc
ndc11	package	73590004501	derived:openfda.package_ndc
spl id		a22ca66a-44ec-efcc-e053-2995a90a027c	id
spl set id		a22c9f95-e3ab-bfd3-e053-2995a90a3c66	set_id
unii		25X51I8RD4	openfda.unii
unii		K72T3FS567	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only When using this product ■ if the following symptoms occurs after use, stop use and consult with a skin specialist red specks, swelling, itching ■ don’t use on the part where there is injury, eczema, or dermatitis Keep out of reach of children ■ if swallowed, get medical help or contact a person control center immediately

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.